RxSight, Inc. Comprehensive Income
RxSight, Inc. (RXST) reported Comprehensive Income of -$12.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-05
- RxSight, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$12.09M.
- RxSight, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$16.00M.
- RxSight, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$9.16M.
- RxSight, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$9.64M.
- RxSight, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$39.06M.
- RxSight, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$27.28M.
- RxSight, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$48.52M.
- RxSight, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$66.83M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$12.09M 10-Q · filed 2026-08-05 | -$28.09M 10-Q · filed 2026-08-05 | -$37.25M derived: sum of 3 quarters · filed 2026-08-05 | -$46.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$16.00M 10-Q · filed 2026-05-06 | -$25.16M derived: sum of 2 quarters · filed 2026-05-06 | -$34.80M derived: sum of 3 quarters · filed 2026-05-06 | -$46.72M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$9.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$18.80M derived: sum of 2 quarters · filed 2026-02-25 | -$30.72M derived: sum of 3 quarters · filed 2026-08-05 | -$39.06M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$9.64M 10-Q · filed 2025-11-05 | -$21.56M derived: sum of 2 quarters · filed 2026-08-05 | -$29.90M 10-Q · filed 2025-11-05 | -$36.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$11.92M 10-Q · filed 2026-08-05 | -$20.26M 10-Q · filed 2026-08-05 | -$26.55M derived: sum of 3 quarters · filed 2026-08-05 | -$32.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$8.34M 10-Q · filed 2026-05-06 | -$14.63M derived: sum of 2 quarters · filed 2026-05-06 | -$20.33M derived: sum of 3 quarters · filed 2026-05-06 | -$26.48M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$6.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$11.99M derived: sum of 2 quarters · filed 2026-02-25 | -$18.14M derived: sum of 3 quarters · filed 2026-02-25 | -$27.28M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$5.70M 10-Q · filed 2025-11-05 | -$11.84M derived: sum of 2 quarters · filed 2025-11-05 | -$20.99M 10-Q · filed 2025-11-05 | -$30.11M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$6.14M 10-Q · filed 2025-08-07 | -$15.29M 10-Q · filed 2025-08-07 | -$24.41M derived: sum of 3 quarters · filed 2026-02-25 | -$36.82M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$9.15M 10-Q · filed 2025-05-07 | -$18.27M derived: sum of 2 quarters · filed 2026-02-25 | -$30.67M derived: sum of 3 quarters · filed 2026-02-25 | -$44.54M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$9.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$21.52M derived: sum of 2 quarters · filed 2026-02-25 | -$35.39M derived: sum of 3 quarters · filed 2026-02-25 | -$48.52M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$12.40M 10-Q · filed 2024-11-07 | -$26.27M derived: sum of 2 quarters · filed 2024-11-07 | -$39.40M 10-Q · filed 2024-11-07 | -$54.96M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$13.87M 10-Q · filed 2024-08-05 | -$26.99M 10-Q · filed 2024-08-05 | -$42.56M derived: sum of 3 quarters · filed 2025-02-25 | -$59.33M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$13.13M 10-Q · filed 2024-05-06 | -$28.69M derived: sum of 2 quarters · filed 2025-02-25 | -$45.47M derived: sum of 3 quarters · filed 2025-02-25 | -$62.28M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$15.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$32.34M derived: sum of 2 quarters · filed 2025-02-25 | -$49.16M derived: sum of 3 quarters · filed 2025-02-25 | -$66.83M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$16.77M 10-Q · filed 2023-11-09 | -$33.59M derived: sum of 2 quarters · filed 2023-11-09 | -$51.26M 10-Q · filed 2023-11-09 | -$67.01M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$16.82M 10-Q · filed 2023-08-07 | -$34.49M 10-Q · filed 2023-08-07 | -$50.23M derived: sum of 3 quarters · filed 2023-08-07 | -$62.91M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$17.67M 10-Q · filed 2023-05-09 | -$33.42M derived: sum of 2 quarters · filed 2023-05-09 | -$46.10M derived: sum of 3 quarters · filed 2023-05-09 | -$59.58M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$15.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$28.42M derived: sum of 2 quarters · filed 2023-03-06 | -$41.90M derived: sum of 3 quarters · filed 2023-03-06 | -$48.70M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$12.68M 10-Q · filed 2022-11-07 | -$26.16M derived: sum of 2 quarters · filed 2022-11-07 | -$32.96M 10-Q · filed 2022-11-07 | -$6.67M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$13.48M 10-Q · filed 2022-08-08 | -$20.28M 10-Q · filed 2022-08-08 | $6.01M derived: sum of 3 quarters · filed 2022-08-08 | $36.66M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$6.80M 10-Q · filed 2022-05-05 | $19.49M derived: sum of 2 quarters · filed 2022-05-05 | $50.14M derived: sum of 3 quarters · filed 2022-05-05 | $37.15M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $26.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $56.94M derived: sum of 2 quarters · filed 2022-03-08 | $43.95M derived: sum of 3 quarters · filed 2022-03-08 | $27.53M 10-K · filed 2022-03-08 |
| 2020-09-30 | $30.65M 10-Q · filed 2021-11-10 | $17.66M derived: sum of 2 quarters · filed 2021-11-10 | $1.23M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$12.99M 10-Q · filed 2021-09-09 | -$29.42M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |